Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

Historic EBT Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 45761.31%.

  • ENDRA Life Sciences' EBT Margin changed N/A to 45761.31% in Q1 2018 from the same period last year, while for Dec 2018 it was 158669.6%, marking a year-over-year decrease of 1571404100.0%. This contributed to the annual value of 10607.97% for FY2024, which is 84232600.0% down from last year.
  • ENDRA Life Sciences' EBT Margin amounted to 45761.31% in Q1 2018.
  • ENDRA Life Sciences' 5-year EBT Margin high stood at 310.52% for Q2 2016, and its period low was 45761.31% during Q1 2018.
  • Over the past 3 years, ENDRA Life Sciences' median EBT Margin value was 1397.52% (recorded in 2017), while the average stood at 13646.3%.
  • Over the last 5 years, ENDRA Life Sciences' EBT Margin had its largest YoY gain of -27888700bps in 2017, and its largest YoY loss of -333647800bps in 2017.
  • Quarter analysis of 3 years shows ENDRA Life Sciences' EBT Margin stood at 133.61% in 2016, then tumbled by -24971bps to 33498.39% in 2017, then tumbled by -37bps to 45761.31% in 2018.
  • Its EBT Margin stands at 45761.31% for Q1 2018, versus 33498.39% for Q4 2017 and 316.69% for Q3 2017.